Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Short term Debt (2016 - 2025)

Historic Short term Debt for Pediatrix Medical (MD) over the last 13 years, with Q3 2025 value amounting to $25.3 million.

  • Pediatrix Medical's Short term Debt rose 3145.36% to $25.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.3 million, marking a year-over-year increase of 3145.36%. This contributed to the annual value of $20.5 million for FY2024, which is 3776.57% up from last year.
  • Per Pediatrix Medical's latest filing, its Short term Debt stood at $25.3 million for Q3 2025, which was up 3145.36% from $23.7 million recorded in Q2 2025.
  • In the past 5 years, Pediatrix Medical's Short term Debt ranged from a high of $25.3 million in Q3 2025 and a low of $2.5 million during Q4 2021
  • Over the past 5 years, Pediatrix Medical's median Short term Debt value was $14.9 million (recorded in 2023), while the average stood at $16.8 million.
  • In the last 5 years, Pediatrix Medical's Short term Debt soared by 49831.33% in 2022 and then fell by 2.01% in 2023.
  • Quarter analysis of 5 years shows Pediatrix Medical's Short term Debt stood at $2.5 million in 2021, then surged by 498.31% to $14.9 million in 2022, then grew by 0.1% to $14.9 million in 2023, then skyrocketed by 37.77% to $20.5 million in 2024, then increased by 23.33% to $25.3 million in 2025.
  • Its Short term Debt was $25.3 million in Q3 2025, compared to $23.7 million in Q2 2025 and $22.1 million in Q1 2025.